Children's Hospital of Philadelphia: Cystic Fibrosis trials

The registry lists 14 Cystic Fibrosis studies with Children's Hospital of Philadelphia as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 2Phase 2 3Phase 3 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Genetics of Insulin and Incretins in Cystic FibrosisRecruitingNCT01852448
• Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)CompletedNCT03551691Phase 2Results posted
• Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis)TerminatedNCT00590538Phase 1/2Results posted
• Alternate Measures of Glucose During OGTT Testing for CFRDCompletedNCT05568134
• Orkambi Treatment in 2 to 5 Year Old Children With CFCompletedNCT03795363
• Ivacaftor Treatment in 4 Month to 2 Year Old CF SubjectsCompletedNCT03783286
• Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose IntoleranceCompletedNCT02776098
• Energy Balance and Weight Gain With Ivacaftor TreatmentCompletedNCT02141464
• Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)CompletedNCT02039986
• Vitamin D3 for the Treatment of Low Vitamin D in Cystic FibrosisWithdrawnNCT00762918Phase 3
• Nasal Potential Difference (NPD) for the Diagnosis of Cystic FibrosisCompletedNCT00589745Not applicable
• Malabsorption Blood Test:Toward a Novel Approach to Quantify SteatorrheaCompletedNCT00572975Phase 4
• Repaglinide for Adolescents With Cystic Fibrosis-Related DiabetesWithdrawnNCT00231192Not applicable
• Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)CompletedNCT00016744Phase 1/2